May 5, 2016

 

Via EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

 

Attention:	Suzanne Hayes
	Re:     Oncobiologics, Inc. Registration Statement No. 333-209011

 

 

Ladies and Gentlemen:

 

Reference is made to our letter, filed as correspondence via EDGAR on May 4, 2016, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for May 5, 2015 at 4:00 p.m. Eastern time in accordance with Rule 461 of the Securities Act of 1933, as amended.

 

As representatives of the several underwriters of the proposed public offering, we hereby respectfully withdraw our request for acceleration of the effectiveness of the above-referenced Registration Statement set forth in our May 4, 2016 letter.

 

 

 

 

 

	Very truly yours,
	JEFFERIES LLC
	By:	/s/ Ashley Delp Walker
		Name: Ashley Delp Walker Title: Managing Director

 

	BARCLAYS CAPITAL INC.
	By:	/s/ Victoria Hale
		Name: Victoria Hale Title: Vice President

 

 

 

 

 

 

cc:		Pankaj Mohan, Oncobiologics, Inc.
		Lawrence Kenyon, Oncobiologics, Inc.
		Stuart M. Cable, Goodwin Procter LLP
		Edwin O’Connor, Goodwin Procter LLP
		Seo Salimi, Goodwin Procter LLP
		Yvan-Claude Pierre, Cooley LLP
		Daniel I. Goldberg, Cooley LLP
		Marianne Sarrazin, Cooley LLP

 

 

 

 

 

 

 

[Signature Page to Withdrawal of Underwriters’ Acceleration Request]